Wells Fargo Reaffirms Their Hold Rating on McKesson (MCK)
In a report released yesterday, Stephen Baxter from Wells Fargo maintained a Hold rating on McKesson, with a price target of $812.00. The company’s shares closed yesterday at $734.69.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
According to TipRanks, Baxter is a 3-star analyst with an average return of 1.2% and a 47.34% success rate. Baxter covers the Healthcare sector, focusing on stocks such as McKesson, Humana, and Community Health.
McKesson has an analyst consensus of Strong Buy, with a price target consensus of $957.56.
Based on McKesson’s latest earnings release for the quarter ending March 31, the company reported a quarterly revenue of $96.3 billion and a net profit of $1.68 billion. In comparison, last year the company earned a revenue of $90.82 billion and had a net profit of $1.26 billion
Based on the recent corporate insider activity of 49 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of MCK in relation to earlier this year. Most recently, in February 2026, Maria Martinez, a Director at MCK sold 349.00 shares for a total of $328,011.14.
Read More on MCK:
